STAAR Surgical | STAA - Gross Profit On Sales


STAAR Surgical reported $43.74M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Bausch Health Companies USD 1.93B 165M Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
Cerus USD 33.33M 8.66M Dec/2024
Cooper Companies USD 695.2M 44.4M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
J&J USD 16.6B 118M Dec/2025
Merit Medical Systems USD 195.35M 8.94M Dec/2025
Novartis USD 10.25B 570M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Orthofix International USD 153.28M 4.76M Dec/2025
Rockwell Medical USD 4.55M 1.49M Jun/2024
STAAR Surgical USD 43.74M 34.13M Dec/2025
Utah Medical Products USD 5.8M 450K Sep/2024